All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
AUDENTES THERAPEUTICS, INC.: Last Reported 12/31/2019

Business Address

600 CALIFORNIA ST., 17TH FLOOR

SAN FRANCISCO, CA US 94108

Mailing Address

600 CALIFORNIA ST., 17TH FLOOR

SAN FRANCISCO, CA US 94108
Phone Number: 415-638-6556 / State Incorporated: DE / Fiscal Year End 12/31

Balance Sheet

Date 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 6/30/2015 3/31/2015 12/31/2014 12/31/2013
Cash and Cash Equivalents $63,590,000.00 $99,000,000.00 $133,160,000.00 $144,349,000.00 $104,339,000.00 $214,495,000.00 $230,864,000.00 $38,967,000.00 $53,531,000.00 $54,574,000.00 $18,764,000.00 $36,359,000.00 $87,067,000.00 $12,456,000.00 $59,713,000.00 $72,058,000.00 $9,563,000.00 $12,900,000.00 -- $45,599,000.00 $12,946,000.00
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $4,919,000.00 $14,203,000.00 $3,651,000.00 $5,465,000.00 $4,642,000.00 $4,997,000.00 $3,155,000.00 $3,315,000.00 $3,667,000.00 $3,563,000.00 $3,358,000.00 $2,824,000.00 $4,846,000.00 $8,579,000.00 -- $3,682,000.00 -- -- -- -- --
Total Current Assets $356,383,000.00 $392,841,000.00 $373,155,000.00 $419,772,000.00 $285,328,000.00 $319,431,000.00 $329,373,000.00 $137,010,000.00 $160,532,000.00 $149,391,000.00 $85,906,000.00 $108,437,000.00 $125,268,000.00 $69,275,000.00 -- $99,639,000.00 -- -- -- -- --
Property Plant and Equipement $38,165,000.00 $37,467,000.00 $34,731,000.00 $32,099,000.00 $30,653,000.00 $29,340,000.00 $26,436,000.00 $24,372,000.00 $22,759,000.00 $22,245,000.00 $19,489,000.00 $18,936,000.00 $18,885,000.00 $16,653,000.00 -- $2,968,000.00 -- -- -- -- --
Intangible Assets Net $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 $8,000,000.00 -- $8,000,000.00 -- -- -- -- --
Goodwill $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 $3,631,000.00 -- $3,631,000.00 -- -- -- -- --
Other Assets $6,722,000.00 $6,850,000.00 $5,305,000.00 $5,305,000.00 $5,305,000.00 $2,045,000.00 $2,045,000.00 $2,045,000.00 $2,045,000.00 $2,045,000.00 $1,433,000.00 $33,000.00 $36,000.00 $36,000.00 -- $301,000.00 -- -- -- -- --
Total Assets $441,508,000.00 $478,114,000.00 $455,176,000.00 $472,555,000.00 $337,773,000.00 $366,051,000.00 $373,089,000.00 $178,662,000.00 $200,247,000.00 $188,592,000.00 $121,739,000.00 $142,057,000.00 $158,750,000.00 $100,525,000.00 -- $117,469,000.00 -- -- -- -- --
Accounts Payable $9,905,000.00 $7,181,000.00 $11,811,000.00 $8,123,000.00 $3,224,000.00 $4,959,000.00 $5,301,000.00 $3,853,000.00 $4,656,000.00 $4,009,000.00 $1,506,000.00 $2,424,000.00 $2,725,000.00 $4,302,000.00 -- $2,789,000.00 -- -- -- -- --
Accrued Liabilities $14,550,000.00 $16,897,000.00 $11,520,000.00 $12,928,000.00 $15,580,000.00 $11,384,000.00 $8,049,000.00 $8,832,000.00 $8,505,000.00 $10,709,000.00 $7,063,000.00 $9,871,000.00 $7,112,000.00 $7,823,000.00 -- $4,797,000.00 -- -- -- -- --
Total Current Liabilities $58,049,000.00 $58,412,000.00 $53,181,000.00 $29,801,000.00 $27,218,000.00 $25,087,000.00 $20,647,000.00 $22,064,000.00 $24,925,000.00 $26,538,000.00 $19,211,000.00 $22,686,000.00 $20,389,000.00 $22,646,000.00 -- $15,780,000.00 -- -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $842,599,000.00 $833,101,000.00 $770,789,000.00 $762,284,000.00 $594,480,000.00 $588,594,000.00 $568,756,000.00 $347,327,000.00 -- -- -- $219,811,000.00 -- -- -- -- -- -- -- -- --
Accumulated Other Comprehensive Loss $226,000.00 $226,000.00 $67,000.00 $-60,000.00 $-47,000.00 $-43,000.00 $-94,000.00 $-80,000.00 $-17,000.00 $-37,000.00 $-29,000.00 $-29,000.00 $-2,000.00 $3,000.00 -- $-10,000.00 -- -- -- -- --
Accumulated Deficit $-459,366,000.00 $-413,600,000.00 $-368,861,000.00 $-319,470,000.00 $-283,878,000.00 $-247,587,000.00 $-216,220,000.00 $-190,649,000.00 $-166,274,000.00 $-141,265,000.00 $-118,526,000.00 $-100,411,000.00 $-80,735,000.00 $-65,366,000.00 -- $-40,743,000.00 -- -- -- -- --
Total Stockholders' Equity $383,459,000.00 $419,702,000.00 $401,995,000.00 $442,754,000.00 $310,555,000.00 $340,964,000.00 $352,442,000.00 $156,598,000.00 $175,322,000.00 $162,054,000.00 $102,528,000.00 $119,371,000.00 $138,361,000.00 $77,879,000.00 -- $101,689,000.00 -- -- -- $59,864,000.00 $12,912,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $441,508,000.00 $478,114,000.00 $455,176,000.00 $472,555,000.00 $337,773,000.00 $366,051,000.00 $373,089,000.00 $178,662,000.00 $200,247,000.00 $188,592,000.00 $121,739,000.00 $142,057,000.00 $158,750,000.00 $100,525,000.00 -- $117,469,000.00 -- -- -- -- --

Statement of Operations

Date 9/30/2019 6/30/2019 3/31/2019 12/31/2018 9/30/2018 6/30/2018 3/31/2018 12/31/2017 9/30/2017 6/30/2017 3/31/2017 12/31/2016 9/30/2016 6/30/2016 3/31/2016 12/31/2015 9/30/2015 6/30/2015 3/31/2015 12/31/2014 12/31/2013
Total Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Research and Development $37,636,000.00 $77,136,000.00 $39,837,000.00 $104,370,000.00 $76,157,000.00 $26,348,000.00 $19,891,000.00 $75,902,000.00 $54,231,000.00 $33,363,000.00 $14,587,000.00 $48,770,000.00 $32,171,000.00 $19,640,000.00 $7,906,000.00 $20,235,000.00 $5,295,000.00 $3,960,000.00 -- $9,280,000.00 --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $146,732,000.00 $98,907,000.00 $51,830,000.00 $134,372,000.00 $96,774,000.00 $59,039,000.00 $26,410,000.00 $93,177,000.00 $66,296,000.00 $41,086,000.00 $18,245,000.00 $60,046,000.00 $40,214,000.00 $14,202,000.00 $10,538,000.00 $26,726,000.00 $16,694,000.00 $5,532,000.00 -- $10,950,000.00 --
Loss from Operations $-146,732,000.00 $-98,907,000.00 $-51,830,000.00 $-37,598,000.00 $-96,774,000.00 $-32,629,000.00 $-26,410,000.00 $-93,177,000.00 $-25,210,000.00 $-22,841,000.00 $-18,245,000.00 $-60,046,000.00 $-15,473,000.00 $-24,741,000.00 $-10,538,000.00 $-26,726,000.00 $-6,999,000.00 $-5,532,000.00 $-4,163,000.00 $-10,950,000.00 --
Loss Before Income Taxes -- -- -- $-128,821,000.00 -- -- -- $-92,484,000.00 -- -- -- $-59,668,000.00 -- -- -- $-26,458,000.00 -- -- -- -- --
Earnings Per Share Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Basic -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Earnings Per Share Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Weighted Average Shares Diluted -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- -- --
Common Stock Shares Authorized 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 300,000,000 50,000,000 -- 50,000,000 -- -- -- -- --
Common Stock Shares Outstanding 45,740,575 45,384,111 43,760,677 43,546,786 37,453,129 37,245,212 36,697,560 29,901,368 29,733,838 27,782,140 21,767,984 21,731,259 21,702,852 2,106,152 -- 2,106,152 -- -- -- -- --
Copyright 2020 PursePoor.com